CD9 and COVID-19: By label-free detection, we observed that most of the exosomes were captured by anti-CD9 and anti-CD41a antibodies, and intriguingly, exosomes of MILD COVID-19 patients were remarkably more abundant compared to those of both SEVERE patients and HDs (Figure 1G).